14 min listen
Rheumatic immune-related adverse events of checkpoint therapy for cancer
FromRMD Open Podcast
ratings:
Length:
6 minutes
Released:
Dec 6, 2017
Format:
Podcast episode
Description
Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about checkpoint inhibitors.
For more information, please visit the RMD Open website, where the related article to this podcast can also be found:
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity: http://rmdopen.bmj.com/content/3/1/e000412.
For more information, please visit the RMD Open website, where the related article to this podcast can also be found:
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity: http://rmdopen.bmj.com/content/3/1/e000412.
Released:
Dec 6, 2017
Format:
Podcast episode
Titles in the series (17)
Interleukin-17: a role in inflammatory arthritis and implication for clinical practice by RMD Open Podcast